<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of neuraxial anesthesia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of neuraxial anesthesia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of neuraxial anesthesia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Unyime Ituk, MBBS, FCARCSI</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Cynthia A Wong, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert Maniker, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marianna Crowley, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2261328"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Neuraxial anesthesia and analgesia techniques include spinal, epidural, and combined spinal-epidural. This topic will discuss aspects of neuraxial anesthesia (NA) that are common to all of these techniques, and the differences among them. The techniques for performing each of them are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique"</a> and  <a class="medical medical_review" href="/z/d/html/89518.html" rel="external">"Epidural and combined spinal-epidural anesthesia: Techniques"</a>.)</p><p>Neuraxial procedures for chronic pain conditions (eg, spinal cord stimulator, epidural steroid injections) are also discussed separately. (See  <a class="medical medical_review" href="/z/d/html/94151.html" rel="external">"Spinal cord stimulation: Placement and management"</a> and  <a class="medical medical_review" href="/z/d/html/7768.html" rel="external">"Subacute and chronic low back pain: Nonsurgical interventional treatment"</a>.)</p><p class="headingAnchor" id="H279224003"><span class="h1">ANATOMY</span><span class="headingEndMark"> — </span>Neuraxial anesthesia is performed by placing a needle between vertebrae and injecting medication into the epidural space (for epidural anesthesia) or the subarachnoid space (for spinal anesthesia). The anatomy relevant for neuraxial anesthesia techniques is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique", section on 'Anatomy'</a> and  <a class="medical medical_review" href="/z/d/html/89518.html" rel="external">"Epidural and combined spinal-epidural anesthesia: Techniques", section on 'Anatomy'</a>.)</p><p class="headingAnchor" id="H200678350"><span class="h1">USE OF NEURAXIAL ANESTHESIA</span><span class="headingEndMark"> — </span>Neuraxial anesthesia (NA) is most commonly used for lower abdominal and lower extremity surgery  (<a class="graphic graphic_table graphicRef114662" href="/z/d/graphic/114662.html" rel="external">table 1</a>). The sensory level required for a specific surgery is determined by the dermatome level of the skin incision and by the level required for surgical manipulation; these two requirements may be very different. As an example, a low abdominal incision for cesarean delivery is made at the T11 to T12 dermatome, but a T4 spinal level is required to prevent pain with peritoneal manipulation  (<a class="graphic graphic_figure graphicRef106237" href="/z/d/graphic/106237.html" rel="external">figure 1</a> and <a class="graphic graphic_table graphicRef106305" href="/z/d/graphic/106305.html" rel="external">table 2</a>).</p><p>Spinal, epidural, and combined spinal-epidural (CSE) anesthesia can be used for many of the same surgical procedures. Differences among them may affect the choice of technique for a specific procedure or patient. The advantages and disadvantages of the various neuraxial anesthesia techniques are shown in a table  (<a class="graphic graphic_table graphicRef110997" href="/z/d/graphic/110997.html" rel="external">table 3</a>). Spinal anesthesia is usually administered as a single injection, whereas epidural anesthesia is usually administered via a catheter for continuous infusion, and CSE anesthesia combines the two. Continuous spinal anesthesia via a catheter sited in the subarachnoid space is less commonly used than the other techniques. (See  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique", section on 'Continuous spinal'</a>.)</p><p>Catheter-based neuraxial anesthesia (ie, epidural, CSE, and continuous spinal) allows prolonged anesthesia and titration of the onset of the anesthetic. Single-shot spinal or epidural anesthesia is limited to the duration of action of the injected drug.</p><p>The needle for spinal anesthesia must be inserted in a mid- to low-lumbar intervertebral space (below the termination of the conus medullaris), whereas needle placement for an epidural injection can occur anywhere from the distal end of the neuraxial canal (via the sacral hiatus to a high cervical interspace [usually for a chronic pain management procedure]). For example, an epidural catheter can be placed to provide primarily thoracic anesthesia and/or postoperative analgesia, with the extent determined by the volume and concentration of the chosen epidural medications. Thus, the specific dermatomes and extent of sensory blockade may be more easily controlled with an epidural injection. </p><p class="headingAnchor" id="H2569371350"><span class="h1">PREOPERATIVE EVALUATION</span><span class="headingEndMark"> — </span>A medical history and anesthesia-directed physical examination should be performed for all patients who undergo any type of anesthesia. If neuraxial anesthesia (NA) is considered, the back should be examined as part of the anesthesia-directed physical examination. (See  <a class="medical medical_review" href="/z/d/html/94539.html" rel="external">"Preoperative evaluation for anesthesia for noncardiac surgery"</a>.)</p><p>When considering NA, we focus the preoperative evaluation on the medical conditions that may alter the physiologic response to NA or increase the risk of complications. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coagulopathy </strong>–<strong> </strong>Patients with abnormal coagulation (ie, with thrombocytopenia, bleeding disorders, receiving anticoagulants) are at increased risk of spinal bleeding during or after neuraxial anesthesia. (See <a class="local">'Spinal-epidural hematoma (SEH)'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic and local skin infection </strong>– Patients with systemic infection, and with skin infection at the site of spinal or epidural needle puncture may be at increased risk for central nervous system (CNS) infection with neuraxial anesthesia. Spinal and epidural needles should not be inserted through obviously infected skin.</p><p></p><p class="bulletIndent1">Chronic infection with human immunodeficiency virus (HIV) is not considered a contraindication to spinal anesthesia since the central nervous system (CNS) is infected early in the course of the disease. </p><p></p><p class="bulletIndent1">The use of NA in patients with other viral infections is controversial. Primary infection with herpes simplex (HSV) and varicella zoster (VZV) is associated with a period of viremia, whereas secondary infection (manifest with oral or genital lesions) is not. Although data are limited, most anesthesiologists are comfortable initiating spinal anesthesia during a secondary HSV outbreak [<a href="#rid1">1</a>], while avoiding insertion of the NA needle through active herpetic skin lesions.</p><p></p><p class="bulletIndent1">The American Society of Anesthesiologists (ASA) Practice Advisory for the Prevention, Diagnosis, and Management of Infectious Complications Associated with Neuraxial Techniques states that there is insufficient evidence to assess whether prophylactic antibiotic therapy reduces the risk of infection [<a href="#rid2">2</a>]. The Advisory recommends that alternative anesthetic techniques be considered in patients at high risk for infection and that preprocedure antibiotic administration be considered when a neuraxial technique is chosen for patients with known or suspected bacteremia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preload-dependent cardiac lesions </strong>– Patients with preload-dependent cardiac lesions (eg, aortic stenosis or hypertrophic cardiomyopathy) are at risk for a profound decrease in cardiac output and hypotension as a result of the sympathectomy that accompanies NA. Management modifications for these patients may include invasive monitoring, incremental initiation of neural blockade, and fluid and vasopressor administration. (See <a class="local">'Cardiovascular'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypovolemia </strong>–<strong> </strong>Hypovolemia increases the risk of hypotension with onset of NA because of the induced sympathectomy; volume status should be normalized prior to initiation of NA, and incremental dosing and invasive blood pressure monitoring may be required.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spine abnormalities</strong> – NA for patients with spine abnormalities (eg, scoliosis, spinal stenosis, disk disease, radiculopathy, prior spine surgery, spina bifida) may be technically challenging or impossible, or associated with increased risk of neurologic complications. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anatomic distortion, surgical scarring, or spine hardware can obliterate the landmarks used for performance of NA techniques. Ultrasound guidance may help in some cases.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Distribution of NA medications may be affected by anatomic distortion or postsurgical changes, and result in inadequate anesthesia or analgesia. This is more likely with an epidural technique, which relies on spread of the drug in the epidural space.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with preexisting neurologic compromise (eg, radiculopathy, spinal stenosis) may be at increased risk of postoperative neurologic complications after NA [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>NA (usually spinal anesthesia) is an option for patients with paraplegia or quadriplegia, in particular to avoid intraoperative autonomic dysreflexia. (See  <a class="medical medical_review" href="/z/d/html/104423.html" rel="external">"Anesthesia for adults with chronic spinal cord injury", section on 'Autonomic dysreflexia'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Progressive neurologic disease </strong>– Patients with progressive or episodic neurologic diseases (eg, multiple sclerosis, post-polio syndrome) are probably not at increased risk of new or worsened neurologic deficits because of neuraxial anesthesia [<a href="#rid4">4</a>]. However, the signs and symptoms of such diseases may worsen in the postoperative period because of the stress of surgery, perioperative fever, or infection. Preexisting neurologic deficits should be documented, and the unknown risks of worsened neurologic disease should be discussed preoperatively. (See  <a class="medical medical_review" href="/z/d/html/4827.html" rel="external">"Perioperative care of the surgical patient with neurologic disease", section on 'Multiple sclerosis'</a> and  <a class="medical medical_review" href="/z/d/html/107587.html" rel="external">"Obstetric and nonobstetric anesthesia for patients with neurologic disorders"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intracranial mass lesion with intracranial hypertension</strong> – Patients with raised intracranial pressure from a mass lesion are at risk for cerebral herniation with spinal anesthesia, or with an unintentional dural puncture during epidural anesthesia, and NA is usually avoided in these patients. Dural puncture is generally considered safe in patients with idiopathic intracranial hypertension. (See  <a class="medical medical_review" href="/z/d/html/107587.html" rel="external">"Obstetric and nonobstetric anesthesia for patients with neurologic disorders"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hydrocephalus with shunt </strong>– NA has been used in patients with shunts in place to treat hydrocephalus, including lumboperitoneal shunts. Theoretical considerations include leakage of cerebrospinal fluid (CSF; with local anesthetic) through the shunt and the risk of shunt infection. (See  <a class="medical medical_review" href="/z/d/html/107587.html" rel="external">"Obstetric and nonobstetric anesthesia for patients with neurologic disorders", section on 'Cerebrospinal fluid shunts'</a>.) </p><p></p><p class="headingAnchor" id="H3402158812"><span class="h2">Laboratory evaluation</span><span class="headingEndMark"> — </span>Preoperative laboratory testing should be performed as it would be for general anesthesia, based on the patient’s medical status and the planned surgical procedure. (See  <a class="medical medical_review" href="/z/d/html/94539.html" rel="external">"Preoperative evaluation for anesthesia for noncardiac surgery", section on 'Preoperative testing'</a>.)</p><p class="headingAnchor" id="H867269"><span class="h1">PHYSIOLOGIC EFFECTS OF NEURAXIAL ANESTHESIA</span><span class="headingEndMark"> — </span>The physiologic effects of neuraxial anesthesia (NA) are the result of blockade of sympathetic, motor and sensory nerves, the compensatory reflexes, and unopposed parasympathetic tone. The magnitude of various physiologic effects depends on the extent and speed of onset of the block, and patient factors.</p><p class="headingAnchor" id="H867437"><span class="h2">Cardiovascular</span><span class="headingEndMark"> — </span>Hypotension and bradycardia are the most common and important physiologic effects of neuraxial anesthesia, and are the result of sympathetic blockade and associated reflexes  (<a class="graphic graphic_figure graphicRef114864" href="/z/d/graphic/114864.html" rel="external">figure 2</a>). </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypotension </strong>–<strong> </strong>Hypotension occurs in as many as 47 percent of spinal anesthetics [<a href="#rid5">5,6</a>], as a result of a decrease in systemic vascular resistance, peripheral blood pooling with decreased venous return to the heart, or both. These two effects result from the sympathetic block that accompanies spinal anesthesia, and from block of adrenal medullary secretion. Higher levels of sympathetic block are associated with an increased risk of hypotension; with spinal block below approximately T4, vasoconstriction above the level of the block may compensate and mitigate the decrease in blood pressure. In addition, block of cardioaccelerator fibers (originating from T1 to T4 nerve roots) with high spinal can contribute to hypotension through a decrease in heart rate and cardiac output. When the same dermatomal block is achieved with epidural and spinal anesthesia, there is a similar incidence of hypotension, although the onset of hypotension may be slower with epidural anesthesia [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1">Risk factors for hypotension include hypovolemia [<a href="#rid8">8</a>], age &gt;40 to 50 years, emergency surgery, obesity, chronic alcohol consumption, and chronic hypertension [<a href="#rid5">5,6,9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bradycardia </strong>– Clinically significant bradycardia occurs in 10 to 15 percent of spinal anesthetics [<a href="#rid6">6,9</a>]. The incidence of bradycardia with epidural anesthesia depends on the level and extent of the block. Mechanisms for bradycardia are direct (blockade of sympathetic cardioaccelerator fibers) and indirect. Indirect mechanisms include decreased output of the myocardial pacemaker cells due to decrease in venous return, stimulation of low-pressure baroreceptors in the right atrium and vena cava, and stimulation of mechanoreceptors in the left ventricle resulting in bradycardia (paradoxical Bezold-Jarisch reflex) [<a href="#rid10">10</a>]. Risk factors for bradycardia during spinal anesthesia include age &lt;50 years, baseline heart rate &lt;60 beats per minute (bpm), American Society of Anesthesiology physical status 1 (ie, healthy, no medical problems), current beta-adrenergic blocker therapy, prolonged PR interval, and block height above T6 [<a href="#rid6">6,9</a>].</p><p></p><p class="bulletIndent1">A small subset of patients develops severe bradycardia that may progress to cardiac arrest. </p><p></p><p class="bulletIndent1">Neuraxial anesthesia can also cause first, second, and third degree heart block [<a href="#rid11">11-16</a>]. The incidence of heart block in this setting is unknown; proposed mechanisms are the same as those for bradycardia. </p><p></p><p class="headingAnchor" id="H867593"><span class="h2">Pulmonary</span><span class="headingEndMark"> — </span>High NA can cause paralysis of accessory muscles of respiration, and can theoretically lead to bronchospasm.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory mechanics</strong> – NA block to a midthoracic level has minimal respiratory effects in patients without pulmonary disease. While intercostal muscles may be paralyzed with a thoracic block, diaphragmatic function is maintained. Therefore, resting tidal volume and the forced expiratory volume in one second/forced vital capacity (FEV1/FVC) ratio are unchanged, and maximum inspiratory volume, vital capacity, and FEV<sub>1</sub> are minimally decreased [<a href="#rid17">17</a>]. </p><p></p><p class="bulletIndent1">In contrast, high spinal block with paralysis of accessory muscles may impair active exhalation and cough, such that peak expiratory flow, maximal minute ventilation, and expiratory reserve volume are reduced [<a href="#rid17">17</a>]. These effects can be important for patients with pulmonary secretions or obstructive pulmonary disease, who depend on accessory muscles of respiration to cough or maintain ventilation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bronchial tone</strong> – Bronchial tone at rest is controlled in part by the balance between parasympathetic and sympathetic bronchial tone. Theoretically, the sympathetic block associated with high spinal anesthesia may allow parasympathetic predominance, and lead to bronchospasm. This effect appears to be of little clinical significance. A study of thoracic level epidural anesthesia in patients with chronic obstructive pulmonary disease reported no increase in airways resistance with sympathetic blockade [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/z/d/html/94354.html" rel="external">"Anesthesia for patients with chronic obstructive pulmonary disease", section on 'Neuraxial anesthesia'</a>.)</p><p></p><p class="headingAnchor" id="H2863919650"><span class="h2">Central nervous system</span><span class="headingEndMark"> — </span>Patients often appear and feel sedated during NA. A number of studies have found a reduction in requirements for sedatives [<a href="#rid19">19-21</a>] and an increase in self-reported and observed sedation [<a href="#rid22">22,23</a>] in patients who undergo spinal anesthesia, compared with those who have not had anesthesia. The unproven hypothesis for this phenomenon is that NA decreases afferent input to the reticular activating system in the brain, resulting in sedation. </p><p>The level of sedation associated with spinal anesthesia can increase over the course of the first 60 minutes after injection [<a href="#rid22">22</a>]. Therefore, sedative medication should be administered in reduced, incremental doses during NA anesthesia, and should be accompanied by continuous monitoring of respiration and consciousness. </p><p>Cerebral blood flow is autoregulated; therefore, blood flow to the brain remains unchanged during NA unless there is a profound drop in blood pressure below the lower limit of autoregulation. </p><p class="headingAnchor" id="H1328556647"><span class="h2">Thermoregulation</span><span class="headingEndMark"> — </span>As with general anesthesia, hypothermia can occur during NA, and may be more likely with higher levels of block [<a href="#rid24">24</a>]. We use active warming methods (ie, warming blankets, fluid warmers) during NA as we would during general anesthesia.</p><p>Patient temperature maintenance in the operating room is multifactorial, and depends on anesthetic effects, operating room temperature, administered fluid volume and temperature, surgical exposure, and the duration of surgery and anesthesia. Several mechanisms may be responsible for heat loss during epidural and spinal anesthesia [<a href="#rid25">25-27</a>] (see  <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">"Perioperative temperature management", section on 'Effects of neuraxial or regional anesthesia'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Sympathetic block redistributes blood flow from the core to the periphery, resulting in loss of heat to the environment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Heat production is decreased because of a decrease in metabolic rate below the level of the block.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Compensatory mechanisms (ie, shivering and vasoconstriction) are blocked below the sensory level.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Central thermoregulation is impaired because of blocked peripheral afferent input.</p><p></p><p class="headingAnchor" id="H1506173879"><span class="h2">Gastrointestinal</span><span class="headingEndMark"> — </span>Sympathetic innervation to the abdominal viscera originates from spinal levels T6 to L1. Parasympathetic innervation to the abdominal viscera is via the vagus nerve, which is not blocked during neuraxial anesthesia. Therefore, depending on the extent of blockade, neuraxial anesthesia results in sympatholysis while maintaining parasympathetic innervation, leading to a contracted gut, relaxed sphincters, and normal peristalsis [<a href="#rid28">28</a>]. This effect can promote the return of gastrointestinal motility after abdominal surgery. A meta-analysis of 22 trials including approximately 1100 patients who underwent abdominal surgery reported that epidural analgesia with local anesthetic with or without opioids reduced the time to first flatus and first bowel movement, compared with opioid analgesia [<a href="#rid29">29</a>].</p><p>The effects of NA on hepatic blood flow are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/91242.html" rel="external">"Anesthesia for the patient with liver disease", section on 'Choice of anesthetic technique'</a>.)</p><p class="headingAnchor" id="H3754064554"><span class="h2">Renal</span><span class="headingEndMark"> — </span>Direct effects of NA on renal function are of little clinical significance, as long as blood pressure and intravascular volume are maintained [<a href="#rid30">30,31</a>]. Innervation to the kidney originates at spinal levels T10 to L1. Neuraxial blockade may alter renal function by several mechanisms, both direct and indirect. Changes in blood pressure, cardiac output, and endocrine function may indirectly affect renal blood flow. Neuraxial blockade may directly affect efferent nerves to the kidney or alter reflex responses due to afferent nerve blockade. However, in healthy individuals, a large reserve protects the kidney from harm, and neuraxial blockade has little physiologic effect as long as hydration is adequate and blood pressure is maintained within the range of autoregulation. In the presence of hypotension, urine output may decrease, but adequate renal oxygenation is maintained, and urine output returns to normal once blood pressure returns to normal.</p><p class="headingAnchor" id="H2261645"><span class="h1">ADVERSE EFFECTS AND COMPLICATIONS</span><span class="headingEndMark"> — </span>Serious and permanent complications of neuraxial anesthesia are very rare. In a prospective audit report from the UK, the incidence of permanent injury from neuraxial anesthesia was 4.2 per 100,000 [<a href="#rid32">32</a>]. This report also highlighted that most injuries resolved within six months.</p><p class="headingAnchor" id="H577023739"><span class="h2">Inadequate or failed neuraxial anesthesia</span><span class="headingEndMark"> — </span>Inadequate or failed neuraxial anesthesia, defined as the need to repeat the neuraxial procedure, convert to general anesthesia, or abort the planned surgery, is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/89518.html" rel="external">"Epidural and combined spinal-epidural anesthesia: Techniques", section on 'Troubleshooting inadequate anesthesia'</a> and  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique"</a>.)</p><p class="headingAnchor" id="H4202569205"><span class="h2">High or total spinal anesthesia</span><span class="headingEndMark"> — </span>Total spinal anesthesia can be a complication of either spinal or epidural anesthesia. It may result from the unrecognized and unintentional injection of medication intended for the epidural space into the subdural or subarachnoid space (via a malpositioned catheter or needle) or an overdose of medication injected into the epidural space. The reported incidence in the obstetric population is 1 in 4336 neuraxial blocks [<a href="#rid33">33</a>]. It usually occurs within a few minutes following administration of local anesthetic, but can also occur up to 40 minutes later with changes in patient position. The signs and symptoms include a rapid ascending sympathetic, sensory, and motor block with associated bradycardia, hypotension, dyspnea, and difficulty with swallowing or phonation. Symptoms can progress to unconsciousness (due to brainstem hypoperfusion and/or brainstem anesthesia), and respiratory depression (secondary to respiratory muscle paralysis and brainstem hypoperfusion). If a large dose of local anesthetic is unintentionally injected into the subarachnoid space, unconsciousness and respiratory depression may be the initial signs of a total spinal anesthesia. </p><p>Injection of local anesthetic solution or <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> into the epidural space either before [<a href="#rid34">34</a>] or after [<a href="#rid35">35</a>] a spinal injection can result in a higher than expected level of spinal anesthesia, or even total spinal anesthesia. Single injection spinal should be performed with caution following failed epidural anesthesia with an appropriate dose of local anesthetic solution. If spinal anesthesia is attempted, a reduced local anesthetic dose should be considered. In one small study in patients who had combined spinal-epidural anesthesia, patients who had 10 mL of saline injected into the epidural space 10 minutes after spinal injection had a higher spinal level 10 minutes later than patients who had no saline injected (mean spinal level T7 versus T11) [<a href="#rid35">35</a>]. Total spinal anesthesia has been described when spinal anesthesia was initiated following failed epidural anesthesia, and is one of the most common serious complications of obstetric anesthesia [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'Failed or inadequate neuraxial block'</a> and  <a class="medical medical_review" href="/z/d/html/89518.html" rel="external">"Epidural and combined spinal-epidural anesthesia: Techniques", section on 'Dose of spinal drugs'</a>.) </p><p class="headingAnchor" id="H3868465535"><span class="h2">Subdural injection</span><span class="headingEndMark"> — </span>The subdural space is a potential space between the dura and arachnoid mater. Unintentional injection of local anesthetic solution into this space (usually intended for the epidural space) may cause a patchy block that results in more extensive cranial anesthesia than expected after epidural injection, with an onset intermediate between spinal and epidural anesthesia [<a href="#rid36">36</a>]. Motor block may also be more extensive than expected. Horner syndrome, apnea, and unconsciousness have been reported after subdural injection of local anesthetic [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H149717219"><span class="h2">Nerve injury</span><span class="headingEndMark"> — </span>Direct trauma to nerve tissue is rare during neuraxial anesthesia. In an audit study from the United Kingdom, the incidence of nerve injury following neuraxial anesthesia for surgical anesthesia (not obstetric) was estimated to be as high as 1.6 per 100,000, if injuries that were not definitively caused by the anesthetic were included in the calculation [<a href="#rid32">32</a>]. The incidence is lower in obstetric patients [<a href="#rid32">32,37</a>]. </p><p>Damage to the conus medullaris may occur during spinal anesthesia if the clinician unintentionally performs spinal anesthesia at a high lumber interspace. Although the spinal cord typically ends at the body of the L1 vertebra in adults, the length varies and may extend lower in some patients [<a href="#rid38">38</a>]. Anesthesia clinicians frequently misidentify the intended interspace, and the actual interspace is cephalad to the intended interspace, sometimes by more than one interspace [<a href="#rid39">39</a>]. Thus, the clinician may be initiating spinal anesthesia at a high- rather than mid-lumber interspace, thereby increasing the risk for direct trauma to the conus medullaris.</p><p>Paresthesias occur frequently during neuraxial procedures, and indicate that the needle or catheter has contacted nerve tissue. However, persistent paresthesia after NA is rare. In a retrospective study of spinal anesthetics, 6.3 percent of patients reported a paresthesia, but only 0.1 percent had persistent postoperative paresthesia [<a href="#rid40">40</a>]. Should a paresthesia occur, needle advancement should be halted. If the paresthesia persists, the needle should be withdrawn.</p><p class="headingAnchor" id="H9031637"><span class="h2">Back pain</span><span class="headingEndMark"> — </span>Localized point tenderness may be present for several days after a neuraxial procedure, but there is no evidence that neuraxial procedures result in long-term backache. In one study, approximately 600 parturients were randomly assigned to receive epidural analgesia or <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">meperidine</a> for labor pain. There was no difference in postpartum backache six months after delivery, in patients with and without backache prior to delivery [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/z/d/html/4469.html" rel="external">"Adverse effects of neuraxial analgesia and anesthesia for obstetrics", section on 'Backache'</a>.)</p><p class="headingAnchor" id="H2261670"><span class="h2">Postdural puncture headache</span><span class="headingEndMark"> — </span>Postdural puncture headache (PDPH) is a positional headache (ie, worse when the patient sits or stands) that usually occurs within 6 to 72 hours of dural puncture [<a href="#rid42">42</a>]. Associated symptoms may include nausea, vomiting, dizziness, tinnitus, neck stiffness, visual change, and hearing loss [<a href="#rid43">43</a>]. PDPH can occur after intentional dural puncture (ie, spinal anesthesia) or after inadvertent dural puncture during epidural anesthesia.</p><p>Risk factors, clinical manifestations, treatment, and complications of PDPH are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/113316.html" rel="external">"Post dural puncture headache"</a> and  <a class="medical medical_review" href="/z/d/html/4469.html" rel="external">"Adverse effects of neuraxial analgesia and anesthesia for obstetrics", section on 'Post dural puncture headache'</a>.) </p><p class="headingAnchor" id="H2009320554"><span class="h2">Urinary retention</span><span class="headingEndMark"> — </span>Spinal anesthesia (and often epidural anesthesia) blocks afferent and efferent nerve signals to the bladder (S2 to S4). Thus, the sensation of urgency from a full bladder is blocked, as is the ability to empty the bladder (detrusor function) [<a href="#rid44">44</a>]. The duration of bladder dysfunction is directly related to the duration of spinal anesthesia. Risk factors for postoperative urinary retention include the use of long-acting local anesthetics, use of intrathecal opioid, older age, male sex, and prolonged surgery [<a href="#rid44">44</a>]. Other factors that may play a role include type of surgery, intraoperative administration of drugs that affect bladder function, intraoperative fluid management, and patient comorbidities.</p><p class="headingAnchor" id="H322731536"><span class="h2">Transient neurologic symptoms</span><span class="headingEndMark"> — </span>Transient neurologic symptoms (TNS) comprise a syndrome including pain and/or dysesthesia in the buttocks or lower extremities several hours after resolution of uncomplicated spinal anesthesia [<a href="#rid45">45</a>]. Onset of pain is typically within 2 to 24 hours after the complete resolution of spinal anesthesia. Pain may be described as mild to severe, usually aching in nature, radiating from the lower back/gluteal region to the posterior thighs. It is often improved by ambulation and nonsteroidal antiinflammatory drug therapy, and usually resolves after several days without sequelae. Physical examination, magnetic resonance imaging, and other electromyographic testing are normal.</p><p>The etiology of transient neurologic symptoms is unclear. Hypotheses include local anesthetic toxicity, needle trauma, ischemia, muscle spasm, and nerve root irritation [<a href="#rid46">46</a>]. TNS can occur after any spinal anesthetic, but is more common when <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> or <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">mepivacaine</a> is used, compared with other local anesthetics [<a href="#rid47">47</a>]. A meta-analysis of 24 trials including 2226 patients reported the risk of TNS with lidocaine for spinal anesthesia was greater compared with <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, <a class="drug drug_general" data-topicid="10228" href="/z/d/drug information/10228.html" rel="external">prilocaine</a>, or procaine; the risk was similar to 2- <a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">chloroprocaine</a> and mepivacaine [<a href="#rid48">48</a>]. The risk of TNS with lidocaine was approximately 1 in 5 with spinal lidocaine. A previous meta-analysis also identified patient position (lithotomy) and type of surgery (knee) as additional risk factors [<a href="#rid49">49</a>]. Dilution of lidocaine with cerebrospinal fluid (CSF) or <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> does not decrease the incidence of symptoms [<a href="#rid50">50</a>]. </p><p>The true incidence of TNS with <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">mepivacaine</a> is unclear. Studies include heterogeneous techniques and few cases of TNS, and have reported TNS in 0 to 37 percent of patients who had spinal anesthesia with various concentrations and doses of the drug [<a href="#rid47">47,49,51</a>]. The best evidence suggests that the incidence of TNS with plain spinal 1.5% mepivacaine is similar to <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>. In a prospective study of approximately 1200 patients, the incidence was 6.5 percent [<a href="#rid52">52</a>]. </p><p class="headingAnchor" id="H1978798405"><span class="h2">Local anesthetic systemic toxicity</span><span class="headingEndMark"> — </span>Local anesthetic systemic toxicity (LAST) can occur with any route of administration of local anesthetics, but is much less likely with spinal than with epidural anesthesia, because such a small dose of local anesthetic (LA) is injected for spinal anesthesia. LAST is a rare but potentially lethal event, that may consist of central nervous system and/or cardiovascular effects ranging from minor manifestations (eg, perioral numbness, tinnitus, twitching), to major events, including seizures, coma, severe hypotension, arrhythmias, and asystole. LAST occurs most commonly with inadvertent intravascular injection of LA with almost immediate onset of signs and symptoms, but delayed onset may also occur with epidural infusion after systemic absorption of LA or migration of the catheter into a blood vessel. LAST is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">"Local anesthetic systemic toxicity"</a>.)</p><p class="headingAnchor" id="H2261682"><span class="h2">Spinal-epidural hematoma (SEH)</span><span class="headingEndMark"> — </span>Hemorrhage into the neuraxis is a rare complication of NA that may occur if a vascular structure is punctured by the needle or catheter. The incidence of SEH following neuraxial anesthesia is unknown, but likely very low, based on retrospective studies with small numbers of hematomas. The incidence of SEH appears to be higher with epidural than with spinal anesthesia. In a 2004 retrospective study, 25 SEHs occurred after approximately 450,000 epidurals (1 in 18,000), and 8 occurred after 1,260,000 spinals (1 in 158,000) [<a href="#rid37">37</a>]. SEH and neuraxial anesthesia for patients who are anticoagulated are discussed separately. Risk factors for SEH include older age, coagulopathy, and a difficult NA procedure. SEH after neuraxial anesthesia is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">"Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication", section on 'Spinal epidural hematoma (SEH)'</a> and  <a class="medical medical_review" href="/z/d/html/4469.html" rel="external">"Adverse effects of neuraxial analgesia and anesthesia for obstetrics", section on 'Spinal epidural hematoma'</a> and  <a class="medical medical_review" href="/z/d/html/94369.html" rel="external">"Anesthesia for the patient with preeclampsia", section on 'Coagulation'</a>.)</p><p class="headingAnchor" id="H1382447055"><span class="h2">Infection</span><span class="headingEndMark"> — </span>The risk of CNS infection with spinal and other neuraxial anesthesia for patients with systemic infection, or with risk factors for infection (eg, diabetes, cancer, or immunocompromise) is unclear. Meningitis is more common after spinal anesthesia, whereas epidural abscess is more common after epidural anesthesia. (See  <a class="medical medical_review" href="/z/d/html/4469.html" rel="external">"Adverse effects of neuraxial analgesia and anesthesia for obstetrics", section on 'Severe infection'</a>.)</p><p>Aseptic technique should routinely be used to reduce the risk of infection and should include skin preparation with <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a> in alcohol solution or <a class="drug drug_general" data-topicid="9801" href="/z/d/drug information/9801.html" rel="external">povidone iodine</a> in alcohol, and the use of hats, masks, and sterile gloves. (See  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique", section on 'Aseptic technique'</a>.)</p><p>Early signs and symptoms of postprocedure infection (eg, back pain, fever, headache, erythema at insertion site) may be followed by later signs (eg, stiff neck, radiating pain, photophobia, loss of motor function, confusion). If any signs of infection occur, an in situ epidural catheter should be removed immediately, and the appropriate imaging and consultation (ie, neurologist or infectious disease specialist) should be initiated. (See  <a class="medical medical_review" href="/z/d/html/1287.html" rel="external">"Clinical features and diagnosis of acute bacterial meningitis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/1292.html" rel="external">"Spinal epidural abscess"</a>.)</p><p class="headingAnchor" id="H2261706"><span class="h1">GENERAL VERSUS NEURAXIAL ANESTHESIA</span><span class="headingEndMark"> — </span>There are risks and benefits to both neuraxial and general anesthesia. Some observational data and small randomized trials suggest that neuraxial anesthesia may be associated with better outcomes than general anesthesia for some procedures [<a href="#rid53">53</a>], but large, high quality evidence is lacking. As a general rule, there are no clear advantages to one type of anesthesia over the other when either would be appropriate [<a href="#rid54">54-56</a>]. Decisions about anesthetic technique should be made at the individual patient level based on a number of factors, including patient, surgeon, and anesthesiologist preference; type of surgical procedure; the patient's comorbid diseases; and plan for postoperative analgesia.</p><p>In addition, the following issues may affect the decision to choose neuraxial anesthesia:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Perioperative process</strong> – The use of neuraxial anesthesia (NA) may modestly increase intraoperative time and recovery room stay for ambulatory procedures. A meta-analysis including over 1000 patients compared general anesthesia with neuraxial anesthesia for ambulatory surgeries [<a href="#rid57">57</a>]. Neuraxial anesthesia was associated with a 35-minute increase in time until ambulatory surgery unit discharge and a 9-minute increase in anesthesia induction time. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Deep vein thrombosis (DVT)</strong> – Surgery is associated with postoperative hypercoagulability and consequent risk of thromboembolic events. Compared with general anesthesia, neuraxial anesthesia is associated with a decreased risk of deep venous thrombosis and pulmonary embolism [<a href="#rid58">58</a>]. The mechanism(s) is unclear, and it is not known if this effect is dependent on the type and extent of neuraxial anesthesia, duration (ie, intraoperative or postoperative), or neuraxial drugs (eg, local anesthetics, opioids). Reduction in risk of DVT with NA is less of a clinical advantage than it was historically, since almost all at-risk patients are now treated with mechanical and pharmacologic prophylaxis for DVT.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood loss</strong> – The effects of NA on perioperative bleeding are unclear, and may depend on the surgery performed. In a meta-analysis of 141 randomized trials including approximately 9500 patients that compared outcomes after general anesthesia with NA, intraoperative and postoperative transfusion requirements were reduced by 50 percent with NA [<a href="#rid58">58</a>]. However, many of the included studies involved orthopedic surgery prior to the routine use of intraoperative <a class="drug drug_general" data-topicid="10011" href="/z/d/drug information/10011.html" rel="external">tranexamic acid</a>. More recent studies involving arthroplasties have shown mixed results, and the largest meta-analysis comparing general anesthesia with NA for total hip and total knee arthroplasty did not evaluate bleeding or transfusion because of low quality studies [<a href="#rid59">59</a>]. (See  <a class="medical medical_review" href="/z/d/html/116322.html" rel="external">"Anesthesia for total knee arthroplasty", section on 'General versus regional anesthesia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cancer recurrence </strong>– The possibility that NA and other regional anesthesia techniques might reduce the rate of cancer recurrence after cancer surgery is a topic of active investigation. The current data are inconclusive, though some randomized trials in specific cancer populations have not found a difference in cancer recurrence or survival. These issues and the relevant literature are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/117029.html" rel="external">"Anesthesia and cancer recurrence", section on 'Regional anesthesia/analgesia'</a>.)</p><p></p><p class="headingAnchor" id="H1012029984"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/120196.html" rel="external">"Society guideline links: Post dural puncture headache"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/129632.html" rel="external">"Society guideline links: Local and regional anesthesia"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/129826.html" rel="external">"Society guideline links: Local anesthetic systemic toxicity"</a>.)</p><p class="headingAnchor" id="H1163598458"><span class="h1">PATIENTS WITH SUSPECTED OR CONFIRMED COVID-19</span><span class="headingEndMark"> — </span>Regional anesthesia is not contraindicated in patients with COVID-19. Regional anesthesia may avoid the need for general anesthesia and airway management, with associated aerosolization of airway secretions and viral spread. The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.asra.com%2Fguidelines-articles%2Foriginal-articles%2Fcovid-19-resources%2Fcovid-19-resources%2Flegacy-b-blog-posts%2F2020%2F04%2F01%2Fpractice-recommendations-on-neuraxial-anesthesia-and-peripheral-nerve-blocks-during-the-covid-19-pandemic&amp;token=98q%2F6EeL9fhrlaNDtKqQAeXGl3tGijjJmtYH%2FvxuLEEZgkMm9R07n5CnjSbd%2BuG9r6OTNmJ5Y2xm6msklGqwl1m8duXy%2BS2Nlt%2FaB%2FGYOYcGUkTA2rNbK9ThMQJcBshJrlZLjg%2B69byKYz5XQiMZC4ojQmUGvUDgNpTjnH9pwvX%2FRggKUXUzxGOINFGgjpXaf80rMcf%2BoEX%2FGtKHIM5JGA%3D%3D&amp;TOPIC_ID=89517" target="_blank">American Society of Regional Anesthesia and Pain Medicine</a> and the European Society of Regional Anesthesia and Pain Therapy have published <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.asra.com%2Fdocs%2Fdefault-source%2Fguidelines-articles%2Fcovid-guidance-ra_r6_final.pdf%3Fsfvrsn%3D2de410cc_4&amp;token=uWxWcfhTZIxBAT2LSxKk15BGNh9AtMOhHTl3aPwQcxP1tM3M4v%2FhihPiqBEE9xr%2FTdbiNZ0If%2B9AB0VD0SETc0oCbCRjRlBsBVMyKyuIMHeXAn9TmquaWA%2FpR3%2BH5amIMn4UnUBzwjmd%2FtEwAdOIjg%3D%3D&amp;TOPIC_ID=89517" target="_blank">practice recommendations</a> for neuraxial anesthesia and peripheral nerve blocks for patients with COVID-19. Important considerations specific to neuraxial anesthesia include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Many patients with COVID-19 will be receiving pharmacologic thromboprophylaxis, which may affect the timing of or decision to use neuraxial anesthesia. (See  <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">"Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication"</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span>Consider checking a platelet count prior to neuraxial anesthesia in symptomatic patients. Thrombocytopenia has been reported in patients with COVID-19 [<a href="#rid60">60,61</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Patients should wear a surgical mask at all times, including throughout the surgical procedure. </p><p class="bulletIndent1"><span class="glyph">●</span>Avoid allowing cerebrospinal fluid (CSF) to drip from the needle when performing spinal anesthesia, and avoid contact with CSF. It is not known whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, enters CSF. However, in patients infected with some other coronaviruses, those viruses have been detected in CSF [<a href="#rid62">62</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>For patients who develop post dural puncture headache, consider avoiding nasal sphenopalatine block, which could provoke cough or sneeze and viral spread. Some experts suggest avoiding an epidural blood patch if possible, to avoid seeding the central nervous system in patients who are viremic.</p><p></p><p>UpToDate topic reviews of COVID-19 related issues include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/127481.html" rel="external">"COVID-19: Perioperative risk assessment, preoperative screening and testing, and timing of surgery after infection"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/127429.html" rel="external">"COVID-19: Management in hospitalized adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/140910.html" rel="external">"Overview of infection control during anesthetic care", section on 'Infectious agents transmitted by aerosol (eg, COVID-19)'</a>.)</p><p></p><p class="headingAnchor" id="H2267956"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for neuraxial anesthesia</strong> – Neuraxial anesthesia (NA; ie, spinal, epidural, and combined spinal-epidural techniques) are most commonly used for lower extremity and lower abdominal surgery. An epidural catheter can also be used to provide anesthesia and/or analgesia for thoracic surgery. (See <a class="local">'Use of neuraxial anesthesia'</a> above.)</p><p></p><p class="bulletIndent1">Decisions on whether to use general and neuraxial anesthesia must be made on a case by case basis, considering factors such as patient, surgeon, and anesthesiologist preference, type of surgical procedure, patient comorbidities, and plan for postoperative analgesia. (See <a class="local">'General versus neuraxial anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preanesthesia evaluation</strong> –<strong> </strong>The preanesthesia evaluation for patients in whom NA is considered should focus on those conditions that may alter the physiologic response to NA or increase the risk of complications, including coagulopathy, systemic or local infection, preload dependent cardiac lesions, hypovolemia, spine abnormalities, progressive neurologic disease, and intracranial mass lesions with intracranial hypertension. (See <a class="local">'Preoperative evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physiologic effects</strong> – The physiologic effects of neuraxial anesthesia are the result of blockade of sympathetic, motor, and sensory nerves, the compensatory reflexes, and unopposed parasympathetic tone.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypotension and bradycardia are the most important and common cardiovascular effects of NA. (See <a class="local">'Cardiovascular'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mid to high neuraxial block can paralyze accessory muscles of respiration and can impair active exhalation and cough. (See <a class="local">'Pulmonary'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients often appear and feel sedated during neuraxial anesthesia. Sedative medication should be administered in reduced, incremental doses, titrated to effect. (See <a class="local">'Central nervous system'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Similar to general anesthesia, hypothermia can occur during NA. Temperature should be monitored and active warming devices should be used to maintain normothermia. (See <a class="local">'Thermoregulation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The sympathetic block associated with NA can result in parasympathetic predominance of innervation to abdominal viscera, resulting in a contracted gut, relaxed sphincters, and normal peristalsis. (See <a class="local">'Gastrointestinal'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – Serious and permanent complications of NA are very rare.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>High spinal block (cervical spinal nerves or higher) consists of a rapidly ascending sympathetic, sensory, and motor block with associated bradycardia, hypotension, dyspnea, and difficulty with swallowing or phonation. Unconsciousness can occur as well. (See <a class="local">'High or total spinal anesthesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unintentional subdural injection of local anesthetic solution, which usually occurs during attempted epidural anesthesia, can cause a patchy block, with a higher sensory level and more extensive motor block than expected. (See <a class="local">'Subdural injection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Direct trauma to nerve tissue is rare during neuraxial anesthesia; paresthesias occur frequently during NA procedures, but persistent paresthesias are rare. (See <a class="local">'Nerve injury'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Localized point tenderness at the injection site may be present for several days after a neuraxial procedure, but there is no evidence that neuraxial procedures result in long-term backache. (See <a class="local">'Back pain'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Postdural puncture headache can occur after spinal anesthesia, or after unintentional dural puncture during epidural anesthesia. (See <a class="local">'Postdural puncture headache'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>NA is associated with postoperative urinary retention, with a duration that is directly related to the duration of the neuraxial block. (See <a class="local">'Urinary retention'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Transient neurologic symptoms (TNS) comprise a syndrome of pain and/or dysesthesia in the buttocks or lower extremities after spinal anesthesia. TNS occurs most commonly after spinal anesthesia with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> or <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">mepivacaine</a>. (See <a class="local">'Transient neurologic symptoms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Local anesthetic systemic toxicity (LAST) is a rare but potentially lethal event that can include central nervous system and/or cardiovascular effects ranging from minor manifestations to major events including seizures and asystole. LAST is much less common after spinal anesthesia than after epidural anesthesia. (See <a class="local">'Local anesthetic systemic toxicity'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Spinal epidural hematoma (SEH) can rarely occur after an NA procedure if a vascular structure is punctured with a needle or catheter, and appears to be more common with epidural than with spinal anesthesia. Risk factors for SEH include coagulopathy, advanced age, and difficult NA procedures. (See <a class="local">'Spinal-epidural hematoma (SEH)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Strict aseptic technique should be followed during NA procedures, to reduce the risk of CNS infection. (See <a class="local">'Infection'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bader AM, Camann WR, Datta S. Anesthesia for cesarean delivery in patients with herpes simplex virus type-2 infections. Reg Anesth 1990; 15:261.</a></li><li><a class="nounderline abstract_t">Practice Advisory for the Prevention, Diagnosis, and Management of Infectious Complications Associated with Neuraxial Techniques: An Updated Report by the American Society of Anesthesiologists Task Force on Infectious Complications Associated with Neuraxial Techniques and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology 2017; 126:585.</a></li><li><a class="nounderline abstract_t">Hebl JR, Horlocker TT, Kopp SL, Schroeder DR. Neuraxial blockade in patients with preexisting spinal stenosis, lumbar disk disease, or prior spine surgery: efficacy and neurologic complications. Anesth Analg 2010; 111:1511.</a></li><li><a class="nounderline abstract_t">Hebl JR, Horlocker TT, Schroeder DR. Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders. Anesth Analg 2006; 103:223.</a></li><li><a class="nounderline abstract_t">Hartmann B, Junger A, Klasen J, et al. The incidence and risk factors for hypotension after spinal anesthesia induction: an analysis with automated data collection. Anesth Analg 2002; 94:1521.</a></li><li><a class="nounderline abstract_t">Carpenter RL, Caplan RA, Brown DL, et al. Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology 1992; 76:906.</a></li><li><a class="nounderline abstract_t">Bonica JJ, Kennedy WF Jr, Ward RJ, Tolas AG. A comparison of the effects of high subarachnoid and epidural anesthesia. Acta Anaesthesiol Scand Suppl 1966; 23:429.</a></li><li><a class="nounderline abstract_t">Hogan Q. Cardiovascular response to sympathetic block by regional anesthesia. Reg Anesth 1996; 21:26.</a></li><li><a class="nounderline abstract_t">Tarkkila P, Isola J. A regression model for identifying patients at high risk of hypotension, bradycardia and nausea during spinal anesthesia. Acta Anaesthesiol Scand 1992; 36:554.</a></li><li><a class="nounderline abstract_t">Pollard JB. Cardiac arrest during spinal anesthesia: common mechanisms and strategies for prevention. Anesth Analg 2001; 92:252.</a></li><li><a class="nounderline abstract_t">Bernards CM, Hymas NJ. Progression of first degree heart block to high-grade second degree block during spinal anaesthesia. Can J Anaesth 1992; 39:173.</a></li><li><a class="nounderline abstract_t">Jordi EM, Marsch SC, Strebel S. Third degree heart block and asystole associated with spinal anesthesia. Anesthesiology 1998; 89:257.</a></li><li><a class="nounderline abstract_t">Shen CL, Hung YC, Chen PJ, et al. Mobitz type II AV block during spinal anesthesia. Anesthesiology 1999; 90:1477.</a></li><li><a class="nounderline abstract_t">de Leon-Casasola OA, Lema MJ. Atrioventricular dissociation resulting from combined thoracic epidural and general anesthesia. Acta Anaesthesiol Scand 1992; 36:165.</a></li><li><a class="nounderline abstract_t">Ng KP. Complete heart block during laparotomy under combined thoracic epidural and general anaesthesia. Anaesth Intensive Care 1996; 24:257.</a></li><li><a class="nounderline abstract_t">McHugh, S; Ibson, J . Development of third degree heart block due to thoracic epidural anaesthesia. Injury direct 2012; 43:18.</a></li><li><a class="nounderline abstract_t">Sundberg A, Wattwil M, Arvill A. Respiratory effects of high thoracic epidural anaesthesia. Acta Anaesthesiol Scand 1986; 30:215.</a></li><li><a class="nounderline abstract_t">Groeben H, Schwalen A, Irsfeld S, et al. Pulmonary sympathetic denervation does not increase airway resistance in patients with chronic obstructive pulmonary disease (COPD). Acta Anaesthesiol Scand 1995; 39:523.</a></li><li><a class="nounderline abstract_t">Tverskoy M, Fleyshman G, Bachrak L, Ben-Shlomo I. Effect of bupivacaine-induced spinal block on the hypnotic requirement of propofol. Anaesthesia 1996; 51:652.</a></li><li><a class="nounderline abstract_t">Ben-David B, Vaida S, Gaitini L. The influence of high spinal anesthesia on sensitivity to midazolam sedation. Anesth Analg 1995; 81:525.</a></li><li><a class="nounderline abstract_t">Tverskoy M, Shagal M, Finger J, Kissin I. Subarachnoid bupivacaine blockade decreases midazolam and thiopental hypnotic requirements. J Clin Anesth 1994; 6:487.</a></li><li><a class="nounderline abstract_t">Pollock JE, Neal JM, Liu SS, et al. Sedation during spinal anesthesia. Anesthesiology 2000; 93:728.</a></li><li><a class="nounderline abstract_t">Gentili M, Huu PC, Enel D, et al. Sedation depends on the level of sensory block induced by spinal anaesthesia. Br J Anaesth 1998; 81:970.</a></li><li><a class="nounderline abstract_t">Leslie K, Sessler DI. Reduction in the shivering threshold is proportional to spinal block height. Anesthesiology 1996; 84:1327.</a></li><li><a class="nounderline abstract_t">Kurz A, Sessler DI, Schroeder M, Kurz M. Thermoregulatory response thresholds during spinal anesthesia. Anesth Analg 1993; 77:721.</a></li><li><a class="nounderline abstract_t">Hynson JM, Sessler DI, Glosten B, McGuire J. Thermal balance and tremor patterns during epidural anesthesia. Anesthesiology 1991; 74:680.</a></li><li><a class="nounderline abstract_t">Joris J, Ozaki M, Sessler DI, et al. Epidural anesthesia impairs both central and peripheral thermoregulatory control during general anesthesia. Anesthesiology 1994; 80:268.</a></li><li><a class="nounderline abstract_t">Steinbrook RA. Epidural anesthesia and gastrointestinal motility. Anesth Analg 1998; 86:837.</a></li><li><a class="nounderline abstract_t">Guay J, Nishimori M, Kopp S. Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery. Cochrane Database Syst Rev 2016; 7:CD001893.</a></li><li><a class="nounderline abstract_t">Suleiman MY, Passannante AN, Onder RL, et al. Alteration of renal blood flow during epidural anesthesia in normal subjects. Anesth Analg 1997; 84:1076.</a></li><li><a class="nounderline abstract_t">Papper EM. Spinal and epidural anesthesia. Effects on renal function. Acta Anaesthesiol Scand Suppl 1966; 24:105.</a></li><li><a class="nounderline abstract_t">Cook TM, Counsell D, Wildsmith JA, Royal College of Anaesthetists Third National Audit Project. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth 2009; 102:179.</a></li><li><a class="nounderline abstract_t">D'Angelo R, Smiley RM, Riley ET, Segal S. Serious complications related to obstetric anesthesia: the serious complication repository project of the Society for Obstetric Anesthesia and Perinatology. Anesthesiology 2014; 120:1505.</a></li><li><a class="nounderline abstract_t">Dhir VB, Sharma AG, Kaur M, Gulabani M. Inadvertent high spinal anesthesia as sequelae to epidural injection of normal saline. Anesth Essays Res 2015; 9:109.</a></li><li><a class="nounderline abstract_t">Takiguchi T, Okano T, Egawa H, et al. The effect of epidural saline injection on analgesic level during combined spinal and epidural anesthesia assessed clinically and myelographically. Anesth Analg 1997; 85:1097.</a></li><li><a class="nounderline abstract_t">Rodríguez J, Bárcena M, Taboada-Muñiz M, Alvarez J. Horner syndrome after unintended subdural block. A report of 2 cases. J Clin Anesth 2005; 17:473.</a></li><li><a class="nounderline abstract_t">Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004; 101:950.</a></li><li><a class="nounderline abstract_t">Saifuddin A, Burnett SJ, White J. The variation of position of the conus medullaris in an adult population. A magnetic resonance imaging study. Spine (Phila Pa 1976) 1998; 23:1452.</a></li><li><a class="nounderline abstract_t">Broadbent CR, Maxwell WB, Ferrie R, et al. Ability of anaesthetists to identify a marked lumbar interspace. Anaesthesia 2000; 55:1122.</a></li><li><a class="nounderline abstract_t">Horlocker TT, McGregor DG, Matsushige DK, et al. A retrospective review of 4767 consecutive spinal anesthetics: central nervous system complications. Perioperative Outcomes Group. Anesth Analg 1997; 84:578.</a></li><li><a class="nounderline abstract_t">Loughnan BA, Carli F, Romney M, et al. Epidural analgesia and backache: a randomized controlled comparison with intramuscular meperidine for analgesia during labour. Br J Anaesth 2002; 89:466.</a></li><li><a class="nounderline abstract_t">Amorim JA, Gomes de Barros MV, Valença MM. Post-dural (post-lumbar) puncture headache: risk factors and clinical features. Cephalalgia 2012; 32:916.</a></li><li><a class="nounderline abstract_t">Morgenlander JC. Lumbar puncture and CSF examination. Answers to three commonly asked questions. Postgrad Med 1994; 95:125.</a></li><li><a class="nounderline abstract_t">Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology 2009; 110:1139.</a></li><li><a class="nounderline abstract_t">Schneider M, Ettlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76:1154.</a></li><li><a class="nounderline abstract_t">Pollock JE. Neurotoxicity of intrathecal local anaesthetics and transient neurological symptoms. Best Pract Res Clin Anaesthesiol 2003; 17:471.</a></li><li><a class="nounderline abstract_t">Salazar F, Bogdanovich A, Adalia R, et al. Transient neurologic symptoms after spinal anaesthesia using isobaric 2% mepivacaine and isobaric 2% lidocaine. Acta Anaesthesiol Scand 2001; 45:240.</a></li><li><a class="nounderline abstract_t">Forget P, Borovac JA, Thackeray EM, Pace NL. Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical patients: a network meta-analysis. Cochrane Database Syst Rev 2019; 12:CD003006.</a></li><li><a class="nounderline abstract_t">Zaric D, Pace NL. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst Rev 2009; :CD003006.</a></li><li><a class="nounderline abstract_t">Pollock JE, Liu SS, Neal JM, Stephenson CA. Dilution of spinal lidocaine does not alter the incidence of transient neurologic symptoms. Anesthesiology 1999; 90:445.</a></li><li><a class="nounderline abstract_t">Pawlowski J, Sukhani R, Pappas AL, et al. The anesthetic and recovery profile of two doses (60 and 80 mg) of plain mepivacaine for ambulatory spinal anesthesia. Anesth Analg 2000; 91:580.</a></li><li><a class="nounderline abstract_t">YaDeau JT, Liguori GA, Zayas VM. The incidence of transient neurologic symptoms after spinal anesthesia with mepivacaine. Anesth Analg 2005; 101:661.</a></li><li><a class="nounderline abstract_t">Elsharydah A, Li F, Minhajuddin A, et al. Risk score for major complications after total hip arthroplasty: the beneficial effect of neuraxial anesthesia. A retrospective observational study. Durrent Orthopaedic Practice 2020; 31:156.</a></li><li><a class="nounderline abstract_t">Basques BA, Bohl DD, Golinvaux NS, et al. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip. Bone Joint J 2015; 97-B:689.</a></li><li><a class="nounderline abstract_t">Smith LM, Cozowicz C, Uda Y, et al. Neuraxial and Combined Neuraxial/General Anesthesia Compared to General Anesthesia for Major Truncal and Lower Limb Surgery: A Systematic Review and Meta-analysis. Anesth Analg 2017; 125:1931.</a></li><li><a class="nounderline abstract_t">Neuman MD, Feng R, Carson JL, et al. Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults. N Engl J Med 2021; 385:2025.</a></li><li><a class="nounderline abstract_t">Liu SS, Strodtbeck WM, Richman JM, Wu CL. A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials. Anesth Analg 2005; 101:1634.</a></li><li><a class="nounderline abstract_t">Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000; 321:1493.</a></li><li><a class="nounderline abstract_t">Johnson RL, Kopp SL, Burkle CM, et al. Neuraxial vs general anaesthesia for total hip and total knee arthroplasty: A systematic review of comparative-effectiveness research. Br J Anaesth 2016; 116:163.</a></li><li><a class="nounderline abstract_t">Bauer ME, Chiware R, Pancaro C. Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports. Anesth Analg 2020; 131:e22.</a></li><li><a class="nounderline abstract_t">Kim JH, Shrestha N, Girshin M. Unexpected Severe Thrombocytopenia in the COVID-19 Positive Parturient. Anesth Analg 2020; 131:e116.</a></li><li><a class="nounderline abstract_t">Yeh EA, Collins A, Cohen ME, et al. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 2004; 113:e73.</a></li></ol></div><div id="topicVersionRevision">Topic 89517 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2271471" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Anesthesia for cesarean delivery in patients with herpes simplex virus type-2 infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28114178" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Practice Advisory for the Prevention, Diagnosis, and Management of Infectious Complications Associated with Neuraxial Techniques: An Updated Report by the American Society of Anesthesiologists Task Force on Infectious Complications Associated with Neuraxial Techniques and the American Society of Regional Anesthesia and Pain Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20861423" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Neuraxial blockade in patients with preexisting spinal stenosis, lumbar disk disease, or prior spine surgery: efficacy and neurologic complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16790657" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12032019" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The incidence and risk factors for hypotension after spinal anesthesia induction: an analysis with automated data collection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1599111" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Incidence and risk factors for side effects of spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6003651" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A comparison of the effects of high subarachnoid and epidural anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8956418" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Cardiovascular response to sympathetic block by regional anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1514341" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : A regression model for identifying patients at high risk of hypotension, bradycardia and nausea during spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11133639" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Cardiac arrest during spinal anesthesia: common mechanisms and strategies for prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1544200" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Progression of first degree heart block to high-grade second degree block during spinal anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9667317" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Third degree heart block and asystole associated with spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10319798" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mobitz type II AV block during spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1549938" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Atrioventricular dissociation resulting from combined thoracic epidural and general anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9133203" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Complete heart block during laparotomy under combined thoracic epidural and general anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Development of third degree heart block due to thoracic epidural anaesthesia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3739578" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Respiratory effects of high thoracic epidural anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7676791" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pulmonary sympathetic denervation does not increase airway resistance in patients with chronic obstructive pulmonary disease (COPD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8758157" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Effect of bupivacaine-induced spinal block on the hypnotic requirement of propofol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7653816" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The influence of high spinal anesthesia on sensitivity to midazolam sedation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7880512" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Subarachnoid bupivacaine blockade decreases midazolam and thiopental hypnotic requirements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10969306" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Sedation during spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10211030" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Sedation depends on the level of sensory block induced by spinal anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8669673" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Reduction in the shivering threshold is proportional to spinal block height.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8214655" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Thermoregulatory response thresholds during spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2008950" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Thermal balance and tremor patterns during epidural anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8311309" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Epidural anesthesia impairs both central and peripheral thermoregulatory control during general anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9539611" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Epidural anesthesia and gastrointestinal motility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27419911" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9141934" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Alteration of renal blood flow during epidural anesthesia in normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6003585" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Spinal and epidural anesthesia. Effects on renal function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19139027" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24845921" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Serious complications related to obstetric anesthesia: the serious complication repository project of the Society for Obstetric Anesthesia and Perinatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25886433" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Inadvertent high spinal anesthesia as sequelae to epidural injection of normal saline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9356106" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The effect of epidural saline injection on analgesic level during combined spinal and epidural anesthesia assessed clinically and myelographically.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16171670" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Horner syndrome after unintended subdural block. A report of 2 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15448529" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Severe neurological complications after central neuraxial blockades in Sweden 1990-1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9670396" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The variation of position of the conus medullaris in an adult population. A magnetic resonance imaging study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11069342" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Ability of anaesthetists to identify a marked lumbar interspace.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9052305" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A retrospective review of 4767 consecutive spinal anesthetics: central nervous system complications. Perioperative Outcomes Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12402727" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Epidural analgesia and backache: a randomized controlled comparison with intramuscular meperidine for analgesia during labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22843225" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Post-dural (post-lumbar) puncture headache: risk factors and clinical features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8202416" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Lumbar puncture and CSF examination. Answers to three commonly asked questions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19352147" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Postoperative urinary retention: anesthetic and perioperative considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8141862" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14529015" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Neurotoxicity of intrathecal local anaesthetics and transient neurological symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11167171" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Transient neurologic symptoms after spinal anaesthesia using isobaric 2% mepivacaine and isobaric 2% lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31786810" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical patients: a network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19370578" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9952151" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Dilution of spinal lidocaine does not alter the incidence of transient neurologic symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10960380" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The anesthetic and recovery profile of two doses (60 and 80 mg) of plain mepivacaine for ambulatory spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16115971" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The incidence of transient neurologic symptoms after spinal anesthesia with mepivacaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Risk score for major complications after total hip arthroplasty: the beneficial effect of neuraxial anesthesia. A retrospective observational study</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25922465" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28537970" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Neuraxial and Combined Neuraxial/General Anesthesia Compared to General Anesthesia for Major Truncal and Lower Limb Surgery: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34623788" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16301234" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11118174" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26787787" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Neuraxial vs general anaesthesia for total hip and total knee arthroplasty: A systematic review of comparative-effectiveness research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32221171" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32371745" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Unexpected Severe Thrombocytopenia in the COVID-19 Positive Parturient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14702500" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
